07:00 , Oct 7, 2013 |  BC Week In Review  |  Company News

Ixico, Phytopharm neurology news

Phytopharm will reverse merge with medical imaging company Ixico Ltd. Phytopharm will initially issue 8 million new ordinary shares to Ixico shareholders and has proposed to issue an additional 465,350 shares. Ixico shareholders will receive...
07:00 , Apr 15, 2013 |  BioCentury  |  Emerging Company Profile

Abcodia: Banking on biomarkers

Abcodia Ltd. is using blood samples that have been taken annually by the U.K. Collaborative Trial for Ovarian Cancer Screening to identify serum biomarkers that can detect breast, lung, pancreatic and colorectal tumors at least...
07:00 , Apr 4, 2011 |  BC Week In Review  |  Company News

Abcodia board of directors update

Abcodia Ltd. , London, U.K.   Business: Diagnostic, Pharmacogenetics   Appointed: Andy Richards as chairman  ...
07:00 , Jul 13, 2009 |  BC Week In Review  |  Company News

Novacta board of directors update

Novacta Biosystems Ltd. , Welwyn Garden City, U.K.   Business: Infectious, Biomanufacturing   Appointed: Andy Richards as chairman; Richard Garraway and Bob Milsted, partners at Celtic Pharma Holdings Advisors LLP   Retiring: Andrew Sandham as...
01:04 , Jul 7, 2009 |  BC Extra  |  Financial News

Novacta raises L13.1 million

Novacta Biosystems Ltd. (Welwyn Garden City, U.K.) raised L13.1 million ($21.1 million) in an equity financing led by new investor Celtic Pharma. Undisclosed existing investors also participated. Novacta's lead compound, NVB302, is in preclinical testing...
07:00 , Sep 8, 1998 |  BC Week In Review  |  Company News

Ascot plc, Chiroscience, Chirotech Technology Ltd. deal

Ascot completed its acquisition of 30 percent of Chirotech, CRO's chiral products subsidiary (see BioCentury, Aug. 17). As part of the completion, CRO executive director Andy Richards exercised his 45,000 remaining options for shares in...